Yazawa N - Search Results

1

Anti-p53 antibodies in patients with dermatomyositis/polymyositis.

Mimura Y, Yazawa N, Tamaki Z, Ashida R, Jinnin M, Asano Y, Tada Y, Kubo M, Ihn H, Tamaki K. Mimura Y, et al. Among authors: yazawa n. Clin Rheumatol. 2007 Aug;26(8):1328-31. doi: 10.1007/s10067-006-0473-1. Epub 2006 Nov 21. Clin Rheumatol. 2007. PMID: 17119861

2

Prevalence of 52-kd and 60-kd Ro/SS-A autoantibodies in Japanese patients with polymyositis/dermatomyositis.

Kubo M, Ihn H, Asano Y, Yamane K, Yazawa N, Tamaki K. Kubo M, et al. Among authors: yazawa n. J Am Acad Dermatol. 2002 Jul;47(1):148-51. doi: 10.1067/mjd.2002.121037. J Am Acad Dermatol. 2002. PMID: 12077598

3

Serum matrix metalloproteinase-3 in systemic sclerosis.

Jinnin M, Ihn H, Asano Y, Yamane K, Yazawa N, Tamaki K. Jinnin M, et al. Among authors: yazawa n. Arch Dermatol Res. 2004 Jun;296(1):25-9. doi: 10.1007/s00403-004-0468-1. Epub 2004 Apr 17. Arch Dermatol Res. 2004. PMID: 15095096

4

Anti-agalactosyl immunoglobulin G antibodies in localized scleroderma.

Mimra Y, Ihn H, Jinnin M, Asano Y, Yamane K, Yazawa N, Tamaki K. Mimra Y, et al. Among authors: yazawa n. Int J Dermatol. 2005 Oct;44(10):817-20. doi: 10.1111/j.1365-4632.2005.02584.x. Int J Dermatol. 2005. PMID: 16207181

5

Serum levels of soluble CD21 in patients with systemic sclerosis.

Tomita M, Kadono T, Yazawa N, Kawashima T, Tamaki Z, Ashida R, Ohmatsu H, Asano Y, Sugaya M, Kubo M, Ihn H, Tamaki K, Sato S. Tomita M, et al. Among authors: yazawa n. Rheumatol Int. 2012 Feb;32(2):317-21. doi: 10.1007/s00296-010-1610-3. Epub 2010 Oct 30. Rheumatol Int. 2012. PMID: 21052675

6

High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement.

Yazawa N, Fujimoto M, Kikuchi K, Kubo M, Ihn H, Sato S, Tamaki T, Tamaki K. Yazawa N, et al. J Rheumatol. 1998 Apr;25(4):650-3. J Rheumatol. 1998. PMID: 9558164

7

Prevalence and antigen specificity of anti-histone antibodies in patients with polymyositis/dermatomyositis.

Kubo M, Ihn H, Yazawa N, Sato S, Kikuchi K, Tamaki K. Kubo M, et al. Among authors: yazawa n. J Invest Dermatol. 1999 May;112(5):711-5. doi: 10.1046/j.1523-1747.1999.00580.x. J Invest Dermatol. 1999. PMID: 10233761 Free article.

8

Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.

Ihn H, Yazawa N, Kubo M, Yamane K, Sato S, Fujimoto M, Kikuchi K, Soma Y, Tamaki K. Ihn H, et al. Among authors: yazawa n. J Rheumatol. 2000 Mar;27(3):698-702. J Rheumatol. 2000. PMID: 10743811

9

Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.

Yamane K, Ihn H, Kubo M, Yazawa N, Kikuchi K, Soma Y, Tamaki K. Yamane K, et al. Among authors: yazawa n. J Rheumatol. 2000 Apr;27(4):930-4. J Rheumatol. 2000. PMID: 10782818

10

Serum KL-6 in adult patients with polymyositis and dermatomyositis.

Kubo M, Ihn H, Yamane K, Kikuchi K, Yazawa N, Soma Y, Tamaki K. Kubo M, et al. Among authors: yazawa n. Rheumatology (Oxford). 2000 Jun;39(6):632-6. doi: 10.1093/rheumatology/39.6.632. Rheumatology (Oxford). 2000. PMID: 10888708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters